Updated Results from a Phase 1 Study of APVO436, a Novel Bispecific Anti-CD123 x Anti-CD3 Adaptir(tm) Molecule, in Relapsed/Refractory Acute Myeloid Leukemia and Myelodysplastic Syndrome
APVO-436
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Updated Results from a Phase 1 Study of APVO436, a Novel Bispecific Anti-CD123 x Anti-CD3 Adaptir(tm) Molecule, in Relapsed/Refractory Acute Myeloid Leukemia and Myelodysplastic Syndrome ### Output: APVO-436